THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Boston Scientific plea deal rejected

Judge suggests probation be part of settlement

Boston Scientific Corp.’s Confient implantable cardioverter defibrillator. Boston Scientific Corp.’s Confient implantable cardioverter defibrillator. (Boston Scientific Corp.)
By Robert Weisman
Globe Staff / April 28, 2010

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

A judge in Minnesota rejected a plea deal yesterday between Boston Scientific Corp. and the US Justice Department and ordered it to be revised, in a surprise move that prolongs the Natick company’s efforts to resolve problems at its heart-device business. (Full article: 854 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass